Provided by Tiger Trade Technology Pte. Ltd.

Nasdaq

99.47
+0.74000.75%
Pre-market: 98.86-0.6100-0.61%05:02 EDT
Volume:1.54M
Turnover:153.28M
Market Cap:55.60B
PE:29.01
High:99.67
Open:98.43
Low:98.26
Close:98.73
52wk High:101.79
52wk Low:76.55
Shares:559.00M
Float Shares:496.00M
Volume Ratio:0.49
T/O Rate:0.31%
Dividend:1.12
Dividend Rate:1.13%
EPS(TTM):3.43
EPS(LYR):3.09
ROE:16.52%
ROA:5.85%
PB:4.64
PE(LYR):32.19

Loading ...

Vertex Report Shows Average US Combined Sales Tax Rate Rises to 10.19%, 10-Year High

Reuters
·
Aug 13

Ascentage Pharma Management Participates in Evercore ISI China Biotech Summit Fireside Chat

Reuters
·
Aug 13

WTW Warns Lithium Supply Chain Concentration in South America Raises Global Disruption Risk

Reuters
·
Aug 13

Outdoor Holding Announces $0.55 Series a Preferred Stock Dividend

Reuters
·
Aug 13

Fluence Starts Construction of 400 MWh Heinersbrück Battery Storage Project with LEAG Clean Power

Reuters
·
Aug 13

Eupraxia Posts Corporate Presentation Detailing Resolve Trial Symptom Response Data

Reuters
·
Aug 13

ZenaTech Signs First Paying AI Data Center Construction Customer for ZenaWorx Drone Monitoring Service

Reuters
·
Aug 13

Euroseas Q2 FY26 Net Income Rises 9.7% to $32.6 Million; Net Revenue Slips 1.2% to $56.5 Million

Reuters
·
Aug 13

High Roller Technologies Signs Exclusive Prediction Markets Platform License, Development Deal with Mrkts.com for ROLR Launch

Reuters
·
Aug 13

Clearmind Advances CMND-100 into Alcohol Use Disorder Patients After Phase I/II Safety Milestone

Reuters
·
Aug 13

Goldera Exploration Subscribes for 2,500,000 Gold Orogen Units for CDN$ 200,000

Reuters
·
Aug 13

Reborn Coffee Signs Agricultural Products Supply Deal Worth at Least $20 Million Annually with Mighty Oak

Reuters
·
Aug 13

CorMedix Q2 2026 Net Income Rises 31.1% to $26 Million; Revenue More than Doubled to $101.9 Million

Reuters
·
Aug 13

Cabaletta Bio Q2 FY26 Net Loss Narrows 11.69% to $51.02 Million; R&D Expenses Rise 18.06% to $44.43 Million

Reuters
·
Aug 13

Intuitive Machines Q2 FY26 Net Loss Narrows to $62.84 Million; Revenue More than Quadruples to $206.17 Million vs Q2 FY25

Reuters
·
Aug 13

Ascendis Pharma Q2 FY26 Swings to Net Profit of €207 Million; Revenue More than Doubles to €339 Million

Reuters
·
Aug 13

SalesCloser Wins Third US Patent for In-Conversation AI Appointment Booking

Reuters
·
Aug 13

MediPharm Labs Swings to Q2 FY26 Profit; Revenue Rises 11% to $10 Million vs Q1 FY26

Reuters
·
Aug 13

Indonesia Energy Drills K-29 Well Past 2,500 Feet, Targets 3,400-Foot Total Depth

Reuters
·
Aug 13

Liminatus Pharma Moves NASDAQ Listing to Capital Market Tier

Reuters
·
Aug 13